PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GSK Head of Patient Recruitment Joins Exco InTouch - Exco InTouch announces the new appointment of Director of Patient Recruitment, Judith Teall
GSK Head of Patient Recruitment Joins Exco InTouch

 

NewswireToday - /newswire/ - Sawbridgeworth, Hertfordshire, United Kingdom, 2010/09/02 - Exco InTouch announces the new appointment of Director of Patient Recruitment, Judith Teall.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Exco InTouch, the leading provider of mobile patient communication solutions for the pharmaceutical and healthcare sectors, announces the new appointment of Director of Patient Recruitment, Judith Teall. The newly created position will drive Exco InTouch to build on its “patient centric” approach to managing clinical trials by identifying barriers to recruitment and retention, enhancing the crucial relationship between patient, trial processes and the sponsor company. Based at Exco InTouch’s European headquarters in Hertfordshire, UK, Teall’s role will see her lead and direct patient engagement solutions, lending her first-rate experience to further develop Exco’s recruitment, retention and compliance suite of services for the company’s biopharmaceutical sponsors and Contract Research Organization (CRO) clients.

Validating Exco InTouch’s growing stature in the eClinical arena, Teall joins the team with a distinguished patient recruitment background from Glaxo SmithKline, where she headed up patient recruitment across Europe, Asia Pacific, Africa and the Middle East. With over 20 years’ experience in the pharmaceutical clinical research area, Teall originally graduated from the Sheffield School of Nursing and spent her early career as a RGN nurse. Teall has an extensive understanding and insight into the healthcare arena through a variety of roles, firmly establishing herself as recruitment expert in the clinical research industry. Her work in guiding recruitment excellence, including developing enrolment strategies and delivering global monitoring training methods strengthens Exco’s global focus on patient recruitment and retention.

“Exco InTouch has been built on a very strong base of experienced personnel coupled with the innovative use of technology and service excellence, and is already well placed in the patient recruitment, retention and compliance arena. This was a key driver in my decision to join the company,” says Teall. “Exco’s industry expertise and commitment to a patient centric approach to developing all its services, made it an ideal match for my expertise in patient recruitment. I am looking forward to further enhancing the standards of global patient recruitment through effective enrolment and engagement strategies.”

Tim Davis, CEO, Exco InTouch, comments: “We believe in putting the patient experience at the heart of everything we do at Exco. Welcoming someone of Judith’s capabilities to our team further enhances our ability to develop these recruitment and engagement strategies and we see Judith as a vital addition to our efforts on this front. With her extensive experience in the industry, we believe Judith will be a key member of the team. Exco has grown significantly by innovative but pragmatic service development especially in the patient recruitment process and with this new appointment we plan to maximise the opportunity for recruitment, communication and engagement with all patient populations.”

Exco InTouch is the leading provider of regulatory compliant mobile technologies for recruitment, retention, compliance, engagement and data capture to the pharmaceutical and healthcare industries.

For further information on the Exco InTouch range of solutions, please call +44 1279 408 210 or +1 949 725 2946

About Exco InTouch
Exco InTouch (excointouch.com) is the leading provider of interactive patient communication solutions using internet and cell phone technology. Using a combination of software and services, Exco InTouch offers BioPharma sponsors, CROs and patient recruitment agencies the opportunity to improve patient recruitment, retention and compliance using timely notifications, alerts and two-way messages.

Additionally, Exco collects electronic patient reported outcomes (ePRO) and diary data using standard cell phone technology which is both cost effective for sponsors and extremely easy and convenient for trial subjects. These solutions are currently being used by hundreds of thousands of patients in over 70 countries, delivered in the local language and are fully compliant with HIPAA regulations, FDA CFR 21 Part 11 and all electronic communication privacy directives.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


GSK Head of Patient Recruitment Joins Exco InTouch

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Scottpr.com 
+44 1477 539539 exco[.]scottpr.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  SKS Media | SKS Associates Ltd

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)